Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Einav Nili Gal-Yam

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
JCO Precision Oncology|December 12, 2023
Lasofoxifene Monotherapy Induces Durable Complete Remission in a Patient with Estrogen Receptor-Positive, Metastatic Breast Cancer with an <i>ESR1</i> MutationEinav Nili Gal-Yam, Keren Levanon
Annual Review of Medicine|October 17, 2007
Cancer epigenetics: modifications, screening, and therapyEinav Nili Gal-Yam, Yoshimasa Saito, Gerda Egger, et al.
Plos Genetics|September 28, 2006
Constitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprintingEinav Nili Gal-Yam, Shinwu Jeong, Amos Tanay, et al.
Harefuah|February 23, 2022
[DELAY IN DIAGNOSIS AND TREATMENT IN BREAST CANCER PATIENTS DURING THE COVID-19 PANDEMIC - CASE STUDY]Inbal Greenhouse, Amit Itay, Miri Sklair Levy, et al.
Journal of Cell Science|September 1, 2005
The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylationRaz Somech, Sigal Shaklai, Orit Geller, et al.
Annals of Hematology|March 17, 2007
Enhanced expression of the nuclear envelope LAP2 transcriptional repressors in normal and malignant activated lymphocytesRaz Somech, Einav Nili Gal-Yam, Sigal Shaklai, et al.
Nucleic Acids Research|November 30, 2005
Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule levelMehrnaz Fatemi, Martha M Pao, Shinwu Jeong, et al.
Cellular Reprogramming|July 12, 2013
Chromatin-modifying agents reactivate embryonic renal stem/progenitor genes in human adult kidney epithelial cells but abrogate dedifferentiation and stemnessDorit Omer, Orit Harari-Steinberg, Ella Buzhor, et al.
Radiology and Oncology|May 16, 2022
Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trialSimona Borstnar, Marketa Palacova, Aleksandra Łacko, et al.
Cancers|January 25, 2025
A Retrospective, Single-Center Study Comparing Neoadjuvant ACTHP vs. DCbHP in HER2-Positive Early Breast Cancer PatientsAmit Itay, Opher Globus, Keren Levanon, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
JCO Precision Oncology|December 12, 2023
Lasofoxifene Monotherapy Induces Durable Complete Remission in a Patient with Estrogen Receptor-Positive, Metastatic Breast Cancer with an <i>ESR1</i> MutationEinav Nili Gal-Yam, Keren Levanon
Annual Review of Medicine|October 17, 2007
Cancer epigenetics: modifications, screening, and therapyEinav Nili Gal-Yam, Yoshimasa Saito, Gerda Egger, et al.
Plos Genetics|September 28, 2006
Constitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprintingEinav Nili Gal-Yam, Shinwu Jeong, Amos Tanay, et al.
Harefuah|February 23, 2022
[DELAY IN DIAGNOSIS AND TREATMENT IN BREAST CANCER PATIENTS DURING THE COVID-19 PANDEMIC - CASE STUDY]Inbal Greenhouse, Amit Itay, Miri Sklair Levy, et al.
Journal of Cell Science|September 1, 2005
The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylationRaz Somech, Sigal Shaklai, Orit Geller, et al.
Annals of Hematology|March 17, 2007
Enhanced expression of the nuclear envelope LAP2 transcriptional repressors in normal and malignant activated lymphocytesRaz Somech, Einav Nili Gal-Yam, Sigal Shaklai, et al.
Nucleic Acids Research|November 30, 2005
Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule levelMehrnaz Fatemi, Martha M Pao, Shinwu Jeong, et al.
Cellular Reprogramming|July 12, 2013
Chromatin-modifying agents reactivate embryonic renal stem/progenitor genes in human adult kidney epithelial cells but abrogate dedifferentiation and stemnessDorit Omer, Orit Harari-Steinberg, Ella Buzhor, et al.
Radiology and Oncology|May 16, 2022
Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trialSimona Borstnar, Marketa Palacova, Aleksandra Łacko, et al.
Cancers|January 25, 2025
A Retrospective, Single-Center Study Comparing Neoadjuvant ACTHP vs. DCbHP in HER2-Positive Early Breast Cancer PatientsAmit Itay, Opher Globus, Keren Levanon, et al.
Pageof 5